Ivosidenib in IDH1-mutated cholangiocarcinoma: Clinical evaluation and future directions
Daniele Lavacchi, Enrico Caliman, Gemma Rossi, Eleonora Buttitta, Cristina Botteri, Sara Fancelli, Elisa Pellegrini, Giandomenico Roviello, Serena Pillozzi, Lorenzo Antonuzzo
Topics & Concepts
IDH1IDH2Isocitrate dehydrogenaseMedicineOncologyInternal medicineAdverse effectDiscontinuationPlaceboClinical endpointClinical trialPharmacologyMutationBiologyPathologyGeneGeneticsEnzymeBiochemistryAlternative medicineCholangiocarcinoma and Gallbladder Cancer StudiesPancreatic and Hepatic Oncology ResearchChromatin Remodeling and Cancer